The latest round-up of the top news in the Medical Devices space, headlined by the acquisition of St Jude $STJ by Abbott Labs $ABT. Thanks as always to Chris Ware (@ware_am_i) for curating.
Abbott to Buy St. Jude Medical in Deal Valued at About $25 Billion
Michelle Cortez, Bloobmerg ($STJ)
St. Jude Medical (STJ) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of St. Jude Medical, Inc.
Press Release ($STJ)
Abbott Labs (ABT) Stock Plunges, Needham Downgrades on St. Jude Acquisition Concerns
U-Jin Lee, The Street ($STJ)
Boston Scientific (BSX) Tops Q1 Earnings, Raises Guidance
Zacks ($BSX)
Edwards CEO: TAVR is a $5 Billion-Plus Opportunity
Arundhati Parmar, Medical Device and Diagnostic Industry ($EW)
Abbott to Buy St. Jude Medical in Deal Valued at About $25 Billion
Michelle Cortez, Bloobmerg ($STJ)
St. Jude Medical (STJ) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of St. Jude Medical, Inc.
Press Release ($STJ)
Abbott Labs (ABT) Stock Plunges, Needham Downgrades on St. Jude Acquisition Concerns
U-Jin Lee, The Street ($STJ)
Boston Scientific (BSX) Tops Q1 Earnings, Raises Guidance
Zacks ($BSX)
Edwards CEO: TAVR is a $5 Billion-Plus Opportunity
Arundhati Parmar, Medical Device and Diagnostic Industry ($EW)
RSS Feed
